Prozac and crime: Who is the victim?

American Journal of Orthopsychiatry

Volumn 72, Issue 3, 2002, Pages 445-455

  Mason, Susan E ^a  

^a YESHIVA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGGRESSION; AGITATION; ANGER; COURT; CRIME; DROWSINESS; HUMAN; INTOXICATION; LAW; LEGAL ASPECT; MANIA; MENTAL DISEASE; PSYCHOPHARMACOTHERAPY; REVIEW; SIDE EFFECT; SUICIDAL BEHAVIOR; UNITED STATES; VICTIM; VIOLENCE; WITNESS; XEROSTOMIA;

ANTISOCIAL PERSONALITY DISORDER; CRIME; CRIME VICTIMS; FEMALE; FLUOXETINE; HOMICIDE; HUMANS; INSANITY DEFENSE; MALE; SEROTONIN UPTAKE INHIBITORS; UNITED STATES;

EID: 0037623982     PISSN: 00029432     EISSN: None     Source Type: Journal    
DOI: 10.1037/0002-9432.72.3.445     Document Type: Review

References (56)

1. Ashley v. State of Georgia, 263 Ga. 820; 439 S. E. 2d 914 (1994).
2. Associated Press. (1996, February 23). Subway firebomber convicted of attempted murder, assault. Retrieved May 22, 2000, from http://132.235.238.184/archives//030896/subway.html
3. Boswell v. State of Florida, 610 So. 2d 670 (1992).
4. Breggin, P. R. (1994). Talking back to Prozac: What doctors aren't telling you about today's most controversial drug. New York: St. Martins.
5. Bulfin v. Lilly et al., 244 Ill. App. 3d 785, 614 N. E. 2d 403, 185 Ill. Dec. 269 (1993).
6. City of Minneapolis v. Altimus, 306 Minn. 462, 238 N. W. 2d 851 (1976).
7. Consalvo v. State of Florida, 697 So. 2d 805 (1996).
8. Cooper v. Oklahoma, 517 US 348, 116 S. Ct. 1373 (1996).
9. Cornwell, J. (1998). The power to harm: Mind, medicine and murder on trial. New York: Penguin.
10. Crundwell, J. K. (1993). Fluoxetine and suicidal ideation: A review of the literature. International Journal of Neuroscience, 68(1-2), 73-84.
11. Dressler, J. (1995). Understanding criminal law (2nd ed.; Legal Text Series). New York: Times Mirror. 18 U. S. C. § 17.
12. Fisher, S., Kent, T. A., & Bryant, S. G. (1995). Postmarketing surveillance by patient self-monitoring: Preliminary data for sertraline versus fluoxetine. Journal of Clinical Psychiatry, 56(7), 288-296.
13. Forsyth et al. v. Eli Lilly et al., No. 95-00185 (D HI, Jan. 5, 1998).
14. Frankenfield, D. L., Baker, S. P., Lange, W. R., Caplan, Y. H., & Smialek, J. E. (1994). Fluoxetine and violent death in Maryland. Forensic Science International, 64(2-3), 107-117.
15. Garza v. State of Texas, 829 S. W. 2d 291 (Tex. Ct. App. 1992).
16. Glenmullen, J. (2000). Prozac backlash: Overcoming the dangers of Prozac, Zoloft, Paxil, and other antidepressants with safe, effective alternatives. New York: Simon & Schuster.
17. Goode, E. (2000, July 18). Once again, Prozac takes center stage in furor. New York Times, p. F1-F2.
18. Harris, M. L. (1999). Problems with Prozac: A defective product responsible for criminal behavior? Journal of Contemporary Legal Issues, 10, 359-548.
19. Healy, D. (1997). The anti-depressant era. Cambridge, MA: Harvard University Press.
20. Hilts, P. J. (2001, June 8). Jury awards $6.4 million in killings tied to drug. New York Times, p. A18.
21. Hirschfeld, R. M. (1999). Management of sexual side effects of antidepressant therapy. Journal of Clinical Psychiatry, 60(Suppl. 14), 27-30.
22. Jick, S. S., Dean, A. D., & Jick, H. (1995, January 28). Anti-depressants and suicide. British Medical Journal, 310, 215-218.
23. Joyce Fentress v. Eli Lilly & Co., Civil Action No. 90-CI-6033, KY 1995.
24. Lyon v. State of Texas, WL 269478 (Tex. App. San Antonio 1996).
25. Mason, S. E., & Pollack, D. (1998). Prozac, families and the law: Implications for social work practice. Clinical Social Work Journal, 26, 317-332.
26. Mazza, D., & Dennerstein, L. (1996). Psychotropic drug use by women: Could violence account for the gender difference? Journal of Psychosomatic Obstetrics and Gynecology, 17(4), 229-234.
27. Medical Economics. (1995). Physicians desk reference (49th ed.). Montvale, NJ: Author.
28. Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis (2nd ed.). Thousand Oaks, CA: Sage.
29. North Carolina v. Alford, 400 U. S. 25, 27 L. Ed. 2d 162, 91 S. Ct. 160 (1970).
30. Peck, C. (1992, June 3). Letter to Ida Hellander, M.D. and Sidney Wolfe, M.D., Health Research Group. Washington, DC: U. S. Department of Health and Human Services.
31. People v. Brown, 50 Cal. Rptr. 2d 407 (1996).
32. People v. Caulley, III, 494 N. W. 2d 853 (1993).
33. People v. Chaffey, 25 Cal. App. 4th 852 (1994).
34. People v. Hammerli, 662 N. E. 2d 452 (1996).
35. People v. Turner, 680 P. 2d 1290 (Colo. Ct. App. 1983).
36. Plaintiffs say Prozac maker concealed crucial evidence at trial (2000, July). Pharmaceutical Litigation Reporter, 16(2), p. 14.
37. Potter v. Lilly et al., 926 S. WW. 2d 449 (Ky 1996).
38. Stake, R. E. (1994). Case studies. In N. K. Denzin & Y. S. Lincoln (Eds.), Handbook of qualitative research (pp. 236-247). Thousand Oaks, CA: Sage.
39. State of Connecticut v. Deangelo, Conn. Super. LEXIS 493, 2000.
40. State of Minnesota v. Ingram, WL 65524 (Minn. App. 1997).
41. State of Ohio v. Pennington, WL 531294 (Ohio App. 1993).
42. State of Utah v. Gardner Jr., 227 Utah Adv. Rep. 28, 870 P. 2d 900, 1993.
43. Strausser v. State of Florida, 682 So. 539 (1996).
44. Swiatek, J. (2000a, April 22). Lilly's legal strategy disarmed Prozac lawyers. Indianpolis Star. Retrieved May 22, 2000, from http:www.starnews.com/news/citystate/0423st_prozac.html
45. Swiatek, J. (2000b, March 1). Successful "Prozac defense" is thought to be the first. Indianapolis Star. Retrieved May 22, 2000, from http://www.psycport.com/news/2000/03/01/krtbrd0000-0199-IN-PROZAC.html
46. Talarico, Jr., v. Dunlap, 281 Ill. App. 3d 622; 677 N. E. 2d 570 (App. Ct. Ill. 1996).
47. Teicher, M., Glod, C., & Cole, J. (1990). Emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry, 147(2), 207-210.
48. Tollefson, G. D., Fawcett, J., Winolur, G., Beasley, C. M. Jr., Potvin, J. H., Faries, D. E., et al. (1993). Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders. Annals of Clinical Psychiatry, 5(4), 209-224.
49. Tollefson, G. D., Rampey, A. H. Jr., Beasley, C. M. Jr., Enas, G. G., & Potvin, J. H. (1994). Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression. Journal of Clinical Psychopharmacology, 14(3), 163-169.
50. United States v. Hensler, 33 F. 3d 1378 (1994).
51. United States v. Hensler, 44 M. J. 184 (1996).
52. Vale, C. M. (1993). The rise and fall of Prozac: Products liability cases and "the Prozac defense" in criminal litigation. Saint Louis University Public Law Review, 12, 523-548.
53. Warshaw, M. G., & Keller, M. B. (1996). The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. Journal of Clinical Psychiatry 57(4), 158-166.
54. Wesbecker jury clears Prozac. (1994, December 12). Retrieved May 22, 2000, from http://lewis.d48.lilly.com/press/1294/121294.html
55. Zajecka, J., Mitchell, S., & Fawcett, J. (1997). Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacology Bulletin, 33, 755-760.
56. Zitrin, R. A., & Langford, C. M. (1999). The moral compass of the American lawyer: Truth justice, power and greed. New York: Ballantine.